Psychiatric complications of treatment with corticosteroids: Review with case report

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 6, 2011, Pages 549-560

  Kenna, Heather A ^a   Poon, Amy W ^a   De Los Angeles, C Paula ^a   Koran, Lorrin M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

anxiety; corticosteroids; delirium; mood; psychosis

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; BENZATROPINE; BENZODIAZEPINE; BETAMETHASONE; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; CORTICOSTEROID; DEXAMETHASONE; DULOXETINE; FLUOCORTOLONE; HALOPERIDOL; HYDROCORTISONE; LAMOTRIGINE; LITHIUM; LORAZEPAM; MEPREDNISONE; METHOTREXATE; MIANSERIN; OLANZAPINE; PREDNISOLONE; PREDNISONE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; STEROID; TRIAMCINOLONE; UNINDEXED DRUG; VALPROIC ACID;

ADD ON THERAPY; AGED; AGGRESSION; AGITATION; ANHEDONIA; ANXIETY; ANXIETY DISORDER; APATHY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; CONFUSION; DATA BASE; DELIRIUM; DELUSION; DEMENTIA; DEPERSONALIZATION; DEPRESSION; DEPRESSIVE PSYCHOSIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; HYPOMANIA; INCIDENCE; INSOMNIA; MANIA; MEDLINE; MENTAL DISEASE; MIXED MANIA AND DEPRESSION; MOOD DISORDER; PANIC; PATHOPHYSIOLOGY; PSYCHOSIS; PSYCINFO; REVIEW; RISK FACTOR; SIDE EFFECT; SUICIDE ATTEMPT; TEMPORAL ARTERITIS;

ADRENAL CORTEX HORMONES; AGED, 80 AND OVER; ARTERITIS; DEPRESSION; FEMALE; HALLUCINATIONS; HUMANS; MENTAL DISORDERS; PREDNISONE;

EID: 80054996643     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02260.x     Document Type: Review

References (124)

1. Da Silva JA, Jacobs JW, Kirwan JR, et al,. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann. Rheum. Dis. 2006; 65: 285-293.
2. Ismail M, Lyster G,. Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Ir. Med. J. 2002; 95: 18-19.
3. Lopez-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M,. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann. Rheum. Dis. 2002; 61: 562-563.
4. Ahmad M, Rasul FM,. Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease. Am. J. Emerg. Med. 1999; 17: 735.
5. Brown ES, Suppes T, Khan DA, Carmody TJ 3rd,. Mood changes during prednisone bursts in outpatients with asthma. J. Clin. Psychopharmacol. 2002; 22: 55-61.
6. Stiefel FC, Breitbart WS, Holland JC,. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest. 1989; 7: 479-491.
7. Curatolo M, Bogduk N,. Pharmacologic pain treatment of musculoskeletal disorders: current perspectives and future prospects. Clin. J. Pain. 2001; 17: 25-32.
8. Deyo RA,. Drug therapy for back pain. Which drugs help which patients? Spine 1996; 21: 2840-2849.
9. Ferris RL, Eisele DW,. Steroid psychosis after head and neck surgery: case report and review of the literature. Otolaryngol. Head Neck Surg. 2003; 129: 591-592.
10. Galen DM, Beck M, Buchbinder D,. Steroid psychosis after orthognathic surgery: a case report. J. Oral Maxillofac. Surg. 1997; 55: 294-297.
11. Fleming PS, Flood TR,. Steroid-induced psychosis complicating orthognathic surgery: a case report. Br. Dent. J. 2005; 199: 647-648.
12. Lewis DA, Smith RE,. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J. Affect. Disord. 1983; 5: 319-332.
13. Naber D, Sand P, Heigl B,. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 1996; 21: 25-31.
14. Ling MH, Perry PJ, Tsuang MT,. Side effects of corticosteroid therapy. Psychiatric aspects. Arch. Gen. Psychiatry 1981; 38: 471-477.
15. Raskin DE,. Steroid-induced panic disorder. Am. J. Psychiatry 1984; 141: 1647.
16. Charbonneau Y, Ravindran AV,. Successful treatment of steroid-induced panic disorder with fluvoxamine. J. Psychiatry Neurosci. 1997; 22: 346-347.
17. Lewis A, Fleminger JJ,. The psychiatric risk from corticotrophin and cortisone. Lancet 1954; 266: 383-386.
18. Wada K, Yamada N, Sato T, et al,. Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001; 42: 461-466.
19. Breitbart W,. Suicide in cancer patients. Oncology 1987; 1: 49-55.
20. Braunig P, Bleistein J, Rao ML,. Suicidality and corticosteroid-induced psychosis. Biol. Psychiatry 1989; 26: 209-210.
21. Finkenbine RD, Frye MD,. Case of psychosis due to prednisone- clarithromycin interaction. Gen. Hosp. Psychiatry 1998; 20: 325-326.
22. d'Orban PT, O'Connor A,. Women who kill their parents. Br. J. Psychiatry 1989; 154: 27-33.
23. Rome HP, Braceland FJ,. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am. J. Psychiatry 1952; 108: 641-651.
24. Brown ES, Khan DA, Nejtek VA,. The psychiatric side effects of corticosteroids. Ann. Allergy Asthma Immunol. 1999; 83: 495-503; quiz 503-494.
25. Bender BG, Lerner JA, Kollasch E,. Mood and memory changes in asthmatic children receiving corticosteroids. J. Am. Acad. Child Adolesc. Psychiatry 1988; 27: 720-725.
26. Hall RC, Popkin MK, Stickney SK, Gardner ER,. Presentation of the steroid psychoses. J. Nerv. Ment. Dis. 1979; 167: 229-236.
27. Varney NR,. A case of reversible steroid dementia. Arch. Clin. Neuropsychol. 1997; 12: 167-171.
28. Sacks O, Shulman M,. Steroid dementia: an overlooked diagnosis? Neurology 2005; 64: 707-709.
29. Sacks O, Shulman M,. Steroid dementia: a follow-up. Neurology 2007; 68: 622.
30. Norra C, Arndt M, Kunert HJ,. Steroid dementia: an overlooked diagnosis? Neurology 2006; 66: 155.
31. Stoudemire A, Anfinson T, Edwards J,. Corticosteroid-induced delirium and dependency. Gen. Hosp. Psychiatry 1996; 18: 196-202.
32. Ortega LD, Grande RG,. Cushing's syndrome due to abuse of dexamethasone nasal spray. Lancet 1979; 2: 96.
33. Brown ES,. Chemical dependence involving glucocorticoids. Ann. Clin. Psychiatry 1997; 9: 185-187.
34. Lupien SJ, McEwen BS,. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res. Rev. 1997; 24: 1-27.
35. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT,. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 1996; 47: 1396-1402.
36. Squire LR,. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 1992; 99: 195-231.
37. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME,. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J. Neurosci. 1994; 14: 2047-2053.
38. Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL,. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen. Psychiatry 1999; 56: 527-533.
39. Wolkowitz OM, Reus VI, Weingartner H, et al,. Cognitive effects of corticosteroids. Am. J. Psychiatry 1990; 147: 1297-1303.
40. Wolkowitz OM, Rubinow D, Doran AR, et al,. Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch. Gen. Psychiatry 1990; 47: 963-968.
41. Mauri M, Sinforiani E, Bono G, et al,. Memory impairment in Cushing's disease. Acta Neurol. Scand. 1993; 87: 52-55.
42. Starkman MN, Gebarski SS, Berent S, Schteingart DE,. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry 1992; 32: 756-765.
43. Starkman MN, Schteingart DE,. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels. Arch. Intern. Med. 1981; 141: 215-219.
44. Denburg SD, Carbotte RM, Denburg JA,. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 1994; 37: 1311-1320.
45. Varney NR, Alexander B, MacIndoe JH,. Reversible steroid dementia in patients without steroid psychosis. Am. J. Psychiatry 1984; 141: 369-372.
46. [No Authors Listed]. Acute adverse reactions to prednisone in relation to dosage. Clin. Pharmacol. Ther. 1972; 13: 694-698.
47. Nishimura K, Harigai M, Omori M, Sato E, Hara M,. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 2008; 33: 395-403.
48. Sirois F,. Steroid psychosis: a review. Gen. Hosp. Psychiatry 2003; 25: 27-33.
49. Brown ES, Chandler PA,. Mood and cognitive changes during systemic corticosteroid therapy. Prim. Care Companion J. Clin. Psychiatry 2001; 3: 17-21.
50. Herbert J,. Neurosteroids, brain damage, and mental illness. Exp. Gerontol. 1998; 33: 713-727.
51. Mitchell A, O'Keane V,. Steroids and depression. BMJ 1998; 316: 244-245.
52. Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES,. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann. Allergy Asthma Immunol. 2004; 92: 500-505.
53. Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S,. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J. Clin. Psychiatry 2000; 61: 261-267.
54. Appenzeller S, Cendes F, Costallat LT,. Acute psychosis in systemic lupus erythematosus. Rheumatol. Int. 2008; 28: 237-243.
55. Gift AG, Wood RM, Cahill CA,. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int. J. Nurs. Stud. 1989; 26: 281-286.
56. Swinburn CR, Wakefield JM, Newman SP, Jones PW,. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br. J. Clin. Pharmacol. 1988; 26: 709-713.
57. Brown ES, Suppes T,. Mood symptoms during corticosteroid therapy: a review. Harv. Rev. Psychiatry 1998; 5: 239-246.
58. Clinician's Ultimate Reference. Available from URL: (last accessed 19 August 2011).
59. Chan L, French ME, Oliver DO, Morris PJ,. High- and low-dose prednisolone. Transplant. Proc. 1981; 13: 336-338.
60. Olsen EA, Carson SC, Turney EA,. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch. Dermatol. 1992; 128: 1467-1473.
61. Chau SY, Mok CC,. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 2003; 61: 104-107.
62. Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M,. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J. Affect. Disord. 2004; 83: 277-281.
63. Nielsen J,. Home visits by psychiatrists. Compr. Psychiatry 1963; 44: 442-460.
64. Patten SB, Neutel CI,. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf. 2000; 22: 111-122.
65. Clark LD, Quarton GC, Cobb S, Bauer W,. Further observations on mental disturbances associated with cortisone and ACTH therapy. N. Engl. J. Med. 1953; 249: 178-183.
66. Jenkins CA, Bruera E,. Difficulties in diagnosing neuropsychiatric complications of corticosteroids in advanced cancer patients: two case reports. J. Pain Symptom Manage. 2000; 19: 309-317.
67. Black AC,. Biochemical mechanisms of steroid-induced psychosis. N. Y. State J. Med. 1982; 82: 1024.
68. Gilad GM, Rabey JM, Gilad VH,. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci. 1987; 40: 2401-2408.
69. Beshay H, Pumariega AJ,. Sertraline treatment of mood disorder associated with prednisone: a case report. J. Child Adolesc. Psychopharmacol. 1998; 8: 187-193.
70. Campbell KM, Schubert DS,. Delirium after cessation of glucocorticoid therapy. Gen. Hosp. Psychiatry 1991; 13: 270-272.
71. Venkatarangam SH, Kutcher SP, Notkin RM,. Secondary mania with steroid withdrawal. Can. J. Psychiatry 1988; 33: 631-632.
72. Judd FK, Burrows GD, Norman TR,. Psychosis after withdrawal of steroid therapy. Med. J. Aust. 1983; 2: 350-351.
73. Mercadante S, Villari P, Intravaia G,. Withdrawal acute psychosis after corticosteroid discontinuation. J. Pain Symptom. Manage. 2007; 34: 118-119.
74. Alpert E, Seigerman C,. Steroid withdrawal psychosis in a patient with closed head injury. Arch. Phys. Med. Rehabil. 1986; 67: 766-769.
75. DeSilva CC, Nurse MC, Vokey K,. Steroid-induced psychosis treated with risperidone. Can. J. Psychiatry 2002; 47: 388-389.
76. Johnson I,. Steroid-induced prepartum psychosis. Br. J. Psychiatry 1996; 169: 522.
77. Ito M, Onose M, Yamada T, Onishi H, Fujisawa S, Kanamori H,. Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: a case report. Jpn. J. Clin. Oncol. 2003; 33: 538-540.
78. Terao T, Mizuki T, Ohji T, Abe K,. Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid. Br. J. Psychiatry 1994; 164: 109-111.
79. Terao T, Yoshimura R, Shiratuchi T, Abe K,. Effects of lithium on steroid-induced depression. Biol. Psychiatry 1997; 41: 1225-1226.
80. Wyszynski AA, Wyszynski B,. Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjogren's syndrome. Psychosomatics 1993; 34: 173-177.
81. Yoshimura R, Ueda N, Nakamura J,. Successful treatment of steroid-induced depression with low dosage of fluvoxamine. Aust. N. Z. J. Psychiatry 2001; 35: 855-856.
82. Benyamin RM, Vallejo R, Kramer J, Rafeyan R,. Corticosteroid induced psychosis in the pain management setting. Pain Physician 2008; 11: 917-920.
83. Bloch M, Gur E, Shalev A,. Chlorpromazine prophylaxis of steroid-induced psychosis. Gen. Hosp. Psychiatry 1994; 16: 42-44.
84. Brown ES, Khan DA, Suppes T,. Treatment of corticosteroid-induced mood changes with olanzapine. Am. J. Psychiatry 1999; 156: 968.
85. Cerullo M,. Corticosteroid-induced mania: Prepare for the unpredictable. Curr. Psychiatry 2006; 5: 43-50.
86. d'Orban PT,. Steroid-induced psychosis. Lancet 1989; 2: 694.
87. Finkenbine R, Gill HS,. Case of mania due to prednisone-clarithromycin interaction. Can. J. Psychiatry 1997; 42: 778.
88. Franco K, Chughtai H,. Steroid-induced mania in poststroke patient involving the right basal ganglion and right frontal region. Psychosomatics 2000; 41: 446-447.
89. Ginsberg DL, Sussman N,. Gabapentin as prophylaxis against steroid-induced mania. Can. J. Psychiatry 2001; 46: 455-456.
90. Hong SI, Cho DH, Kang HC, Chung DJ, Chung MY,. Acute onset of steroid psychosis with very low dose of prednisolone in Sheehan's syndrome. Endocr. J. 2006; 53: 255-258.
91. Kato O, Misawa H,. Steroid-induced psychosis treated with valproic acid and risperidone in a patient with systemic lupus erythematosus. Prim. Care Companion J. Clin. Psychiatry 2005; 7: 312.
92. Lundberg JC, Lee M, Chionchio SB, Theobald DE, Saltzer EB,. A steroid-induced disorder in a patient with non-Hodgkin's lymphoma. Cancer Pract. 2000; 8: 155-159.
93. Muzyk A, Hold S, Gagliardi J,. Corticosteroid psychosis: stop therapy or add psychotropics? Curr. Psychiatry 2010; 9: 61-63, 67- 69.
94. Preda A, Fazeli A, McKay BG, Bowers MB, Mazure CM,. Lamotrigine as prophylaxis against steroid-induced mania. J. Clin. Psychiatry 1999; 60: 708-709.
95. Siddiqui Z, Ramaswamy S, Petty F,. Quetiapine therapy for corticosteroid-induced mania. Can. J. Psychiatry 2005; 50: 77-78.
96. Viswanathan R, Glickman L,. Clonazepam in the treatment of steroid-induced mania in a patient after renal transplantation. N. Engl. J. Med. 1989; 320: 319-320.
97. Artukoglu F,. Single dose dexamethasone induced postoperative psychosis. Canad. J. Anesth. 2007; 54: 43461.
98. Benazzi F,. Resistant depression associated with lupus erythematosus and steroid therapy. Can. J. Psychiatry 1997; 42: 530-531.
99. Koh YI, Choi IS, Shin IS, Hong SN, Kim YK, Sim MK,. Steroid-induced delirium in a patient with asthma: report of one case. Korean J. Intern. Med. 2002; 17: 150-152.
100. Mada S, Palmer C, Mhando Y, Rao P, Erukulapati R, Nag S,. Severe acute psychosis precipitated by replacement dose hydrocortisone in newly diagnosed panhypopituitarism. Endocrine Abstracts. 2009; 19: P228.
101. Okishiro N, Tanimukai H, Tsuneto S, Ito N,. Can 'steroid switching' improve steroid-induced psychosis in a patient with advanced cancer? J. Palliat. Med. 2009; 12: 487-490.
102. Silva RG, Tolstunov L,. Steroid-induced psychosis: report of case. J. Oral Maxillofac. Surg. 1995; 53: 183-186.
103. Daragon A, Vittecoq O, Le Loet X,. Visual hallucinations induced by intraarticular injection of steroids. J. Rheumatol. 1997; 24: 411.
104. Gallerani M, Boari B,. Hallucinations and tremors due to oral therapeutic doses of erythromycin and methylprednisolone. Intern. Emerg. Med. 2008; 3: 283-285.
105. Warrington TP, Bostwick JM,. Psychiatric adverse effects of corticosteroids. Mayo Clin. Proc. 2006; 81: 1361-1367.
106. Ismail K, Wessely S,. Psychiatric complications of corticosteroid therapy. Br. J. Hosp. Med. 1995; 53: 495-499.
107. Richter B, Neises G, Clar C,. Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review. Endocrinol. Metab. Clin. North Am. 2002; 31: 751-778.
108. Fricchione G, Ayyala M, Holmes V,. Steroid withdrawal psychiatric syndrome. Ann. Clin. Psychiatry 1989; 1: 99-108.
109. Wolkowitz OM,. Long-lasting behavioral changes following prednisone withdrawal. JAMA 1989; 261: 1731-1732.
110. Goldman LS, Goveas J,. Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics 2002; 43: 495-497.
111. Budur K, Pozuelo L,. Olanzapine for corticosteroid-induced mood disorders. Psychosomatics 2003; 44: 353.
112. Abbas A, Styra R,. Valproate prophylaxis against steroid induced psychosis. Can. J. Psychiatry 1994; 39: 188-189.
113. Himelhoch S, Haller E,. Extreme mood lability associated with systemic lupus erythematosus and stroke successfully treated with valproic acid. J. Clin. Psychopharmacol. 1996; 16: 469-470.
114. Blazer DG, Petrie WM, Wilson WP,. Affective psychoses following renal transplant. Dis. Nerv. Syst. 1976; 37: 663-667.
115. Siegal FP,. Lithium for steroid-induced psychosis. N. Engl. J. Med. 1978; 299: 155-156.
116. Hall RC, Popkin MK, Kirkpatrick B,. Tricyclic exacerbation of steroid psychosis. J. Nerv. Ment. Dis. 1978; 166: 738-742.
117. Malinow KL, Dorsch C,. Tricyclic precipitation of steroid psychosis. Psychiatr. Med. 1984; 2: 351-354.
118. Brown ES, Vazquez M, Nakamura A,. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol. Psychiatry 2008; 64: 727-729.
119. Brown ES, Wolfshohl J, Shad MU, Vazquez M, Osuji IJ,. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine. Neuropsychopharmacology 2008; 33: 2376-2383.
120. Falk WE, Mahnke MW, Poskanzer DC,. Lithium prophylaxis of corticotropin-induced psychosis. JAMA 1979; 241: 1011-1012.
121. Goggans FC, Weisberg LJ, Koran LM,. Lithium prophylaxis of prednisone psychosis: a case report. J. Clin. Psychiatry 1983; 44: 111-112.
122. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-1998. A 54-year-old woman with a progressive gait disturbance and painful leg paresthesias. N. Engl. J. Med. 1998; 339: 1534-1541.
123. Sabet-Sharghi F, Hutzler JC,. Prophylaxis of steroid-induced psychiatric syndromes. Psychosomatics 1990; 31: 113-114.
124. Brown ES, Denniston D, Gabrielson B, Khan DA, Khanani S, Desai S,. Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts. Allergy Asthma Proc. 2010; 31: 331-336.